Cooperative effects of tumor necrosis factor-α and 1,25-dihydroxyvitamin D3 on growth inhibition, differentiation, and c-myc reduction in human promyelocytic leukemia cell line HL-60

This publication has 17 references indexed in Scilit:

• Tumor Necrosis Factor Reduces c- myc Expression and Cooperates with Interferon-γ in HeLa Cells
  Science, 1986
• Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon.
  The Journal of Experimental Medicine, 1986
• Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
  Science, 1985
• Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor
  Nature, 1985
• Phenotypic differentiation-linked growth inhibition in human leukemia cells by active vitamin D3 analogues
  International Journal of Cancer, 1984
• 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
  The Journal of cell biology, 1984
• Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite
  Nature, 1983
• onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient
  Nature, 1982
• 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells
  Biochemical and Biophysical Research Communications, 1981
• 1,25-DIHYDROXYVITAMIN D₃AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTURE
  Endocrinology, 1981